Cargando…

Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3

To date, information on the ontogeny of renal transporters is limited. Here, we propose to estimate the in vivo functional ontogeny of transporters using a combined population pharmacokinetic (popPK) and physiology-based pharmacokinetic (PBPK) modeling approach called popPBPK. Clavulanic acid and am...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristea, Sînziana, Krekels, Elke H. J., Allegaert, Karel, De Paepe, Peter, de Jaeger, Annick, De Cock, Pieter, Knibbe, Catherijne A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096729/
https://www.ncbi.nlm.nih.gov/pubmed/33948771
http://dx.doi.org/10.1208/s12248-021-00595-9
_version_ 1783688203331436544
author Cristea, Sînziana
Krekels, Elke H. J.
Allegaert, Karel
De Paepe, Peter
de Jaeger, Annick
De Cock, Pieter
Knibbe, Catherijne A. J.
author_facet Cristea, Sînziana
Krekels, Elke H. J.
Allegaert, Karel
De Paepe, Peter
de Jaeger, Annick
De Cock, Pieter
Knibbe, Catherijne A. J.
author_sort Cristea, Sînziana
collection PubMed
description To date, information on the ontogeny of renal transporters is limited. Here, we propose to estimate the in vivo functional ontogeny of transporters using a combined population pharmacokinetic (popPK) and physiology-based pharmacokinetic (PBPK) modeling approach called popPBPK. Clavulanic acid and amoxicillin were used as probes for glomerular filtration, combined glomerular filtration, and active secretion through OAT1,3, respectively. The predictive value of the estimated OAT1,3 ontogeny function was assessed by PBPK predictions of renal clearance (CL(R)) of other OAT1,3 substrates: cefazolin and piperacillin. Individual CL(R) post-hoc values, obtained from a published popPK model on the concomitant use of clavulanic acid and amoxicillin in critically ill children between 1 month and 15 years, were used as dependent variables in the popPBPK analysis. CL(R) was re-parameterized according to PBPK principles, resulting in the estimation of OAT1,3-mediated intrinsic clearance (CL(int,OAT1,3,invivo)) and its ontogeny. CL(int,OAT1,3,invivo) ontogeny was described by a sigmoidal function, reaching half of adult level around 7 months of age, comparable to findings based on renal transporter-specific protein expression data. PBPK-based CL(R) predictions including this ontogeny function were reasonably accurate for piperacillin in a similar age range (2.5 months–15 years) as well as for cefazolin in neonates as compared to published data (%RMSPE of 21.2 and 22.8%, respectively and %PE within ±50%). Using this novel approach, we estimated an in vivo functional ontogeny profile for CL(int,OAT1,3,invivo) that yields accurate CL(R) predictions for different OAT1,3 substrates across different ages. This approach deserves further study on functional ontogeny of other transporters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1208/s12248-021-00595-9.
format Online
Article
Text
id pubmed-8096729
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80967292021-05-05 Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3 Cristea, Sînziana Krekels, Elke H. J. Allegaert, Karel De Paepe, Peter de Jaeger, Annick De Cock, Pieter Knibbe, Catherijne A. J. AAPS J Research Article To date, information on the ontogeny of renal transporters is limited. Here, we propose to estimate the in vivo functional ontogeny of transporters using a combined population pharmacokinetic (popPK) and physiology-based pharmacokinetic (PBPK) modeling approach called popPBPK. Clavulanic acid and amoxicillin were used as probes for glomerular filtration, combined glomerular filtration, and active secretion through OAT1,3, respectively. The predictive value of the estimated OAT1,3 ontogeny function was assessed by PBPK predictions of renal clearance (CL(R)) of other OAT1,3 substrates: cefazolin and piperacillin. Individual CL(R) post-hoc values, obtained from a published popPK model on the concomitant use of clavulanic acid and amoxicillin in critically ill children between 1 month and 15 years, were used as dependent variables in the popPBPK analysis. CL(R) was re-parameterized according to PBPK principles, resulting in the estimation of OAT1,3-mediated intrinsic clearance (CL(int,OAT1,3,invivo)) and its ontogeny. CL(int,OAT1,3,invivo) ontogeny was described by a sigmoidal function, reaching half of adult level around 7 months of age, comparable to findings based on renal transporter-specific protein expression data. PBPK-based CL(R) predictions including this ontogeny function were reasonably accurate for piperacillin in a similar age range (2.5 months–15 years) as well as for cefazolin in neonates as compared to published data (%RMSPE of 21.2 and 22.8%, respectively and %PE within ±50%). Using this novel approach, we estimated an in vivo functional ontogeny profile for CL(int,OAT1,3,invivo) that yields accurate CL(R) predictions for different OAT1,3 substrates across different ages. This approach deserves further study on functional ontogeny of other transporters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1208/s12248-021-00595-9. Springer International Publishing 2021-05-04 /pmc/articles/PMC8096729/ /pubmed/33948771 http://dx.doi.org/10.1208/s12248-021-00595-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Cristea, Sînziana
Krekels, Elke H. J.
Allegaert, Karel
De Paepe, Peter
de Jaeger, Annick
De Cock, Pieter
Knibbe, Catherijne A. J.
Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title_full Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title_fullStr Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title_full_unstemmed Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title_short Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
title_sort estimation of ontogeny functions for renal transporters using a combined population pharmacokinetic and physiology-based pharmacokinetic approach: application to oat1,3
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096729/
https://www.ncbi.nlm.nih.gov/pubmed/33948771
http://dx.doi.org/10.1208/s12248-021-00595-9
work_keys_str_mv AT cristeasinziana estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT krekelselkehj estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT allegaertkarel estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT depaepepeter estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT dejaegerannick estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT decockpieter estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13
AT knibbecatherijneaj estimationofontogenyfunctionsforrenaltransportersusingacombinedpopulationpharmacokineticandphysiologybasedpharmacokineticapproachapplicationtooat13